Search - tctmd.com

Displaying 261 - 271 of 271

Sort: Relevancy | Date

News Conference News

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

Jason Kahn

May 18, 2011

News Industry News

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

May 18, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

Caitlin E. Cox

April 05, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

News Industry News

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

February 02, 2011

News Industry News

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

January 25, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

January 04, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

Advertisement

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future

Therapies Take on In-Stent Restenosis with Mixed Results

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content